Comparison with previous studies
Sentilhes [33] found no cases of thromboembolic disease or
thrombocytopenia among 54 pregnant women with COVID-19 including five
women who were admitted to ICU in Strasbourg. Guan [47] reported one
case of DIC among 1099 cases of laboratory confirmed COVID-19 in
non-pregnant patients of all ages (0.1% of cases). Tang [1] noted a
higher incidence of coagulopathy in non-survivors which is in keeping
with our findings. Whilst uncommon in pregnant women with COVID-19, our
data suggests that the identification of haemostatic and coagulopathic
changes may have value in the identification of women at risk of
deterioration.